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Loss of ATF3 exacerbates liver damage
through the activation of mTOR/p70S6K/
HIF-1α signaling pathway in liver
inflammatory injury
Qiang Zhu1,2, Han Wang1, Bin Jiang2, Xuhao Ni1, Longfeng Jiang1, Changyong Li3, Xuehao Wang1, Feng Zhang1,
Bibo Ke4 and Ling Lu1
Abstract
Activating transcription factor 3 (ATF3) is a stress-induced transcription factor that plays important roles in regulating
immune and metabolic homeostasis. Activation of the mechanistic target of rapamycin (mTOR) and hypoxia-inducible
factor (HIF) transcription factors are crucial for the regulation of immune cell function. Here, we investigated the
mechanism by which the ATF3/mTOR/HIF-1 axis regulates immune responses in a liver ischemia/reperfusion injury (IRI)
model. Deletion of ATF3 exacerbated liver damage, as evidenced by increased levels of serum ALT, intrahepatic
macrophage/neutrophil trafficking, hepatocellular apoptosis, and the upregulation of pro-inflammatory mediators.
ATF3 deficiency promoted mTOR and p70S6K phosphorylation, activated high mobility group box 1 (HMGB1) and
TLR4, inhibited prolyl-hydroxylase 1 (PHD1), and increased HIF-1α activity, leading to Foxp3 downregulation and RORγt
and IL-17A upregulation in IRI livers. Blocking mTOR or p70S6K in ATF3 knockout (KO) mice or bone marrow-derived
macrophages (BMMs) downregulated HMGB1, TLR4, and HIF-1α and upregulated PHD1, increasing Foxp3 and
decreasing IL-17A levels in vitro. Silencing of HIF-1α in ATF3 KO mice ameliorated IRI-induced liver damage in parallel
with the downregulation of IL-17A in ATF3-deficient mice. These findings demonstrated that ATF3 deficiency activated
mTOR/p70S6K/HIF-1α signaling, which was crucial for the modulation of TLR4-driven inflammatory responses and
T cell development. The present study provides potential therapeutic targets for the treatment of liver IRI followed
by liver transplantation.
Introduction
Liver ischemia and reperfusion injury (IRI) is a major
problem associated with liver transplantation and resec-
tion. Liver inflammatory responses induced by IR can
exacerbate liver damage. Macrophages (Kupffer cells) play
a critical role in triggering TLR4-mediated innate immune
responses and in liver inflammation1,2. IR-induced liver
inflammation leads to the release of endogenous damage-
associated molecular pattern (DAMP) molecules, which
activate the TLR4 signaling cascade on Kupffer cells and
the release of pro-inflammatory cytokines leading to the
activation of T cells3–5. Recent studies showed that T cells
can differentiate into IL-17-producing cells, a distinct
CD4+ T cell lineage that is independent from Th1 or Th2
cell development6,7. Th17 cells contribute to the inflam-
matory response by mediating the recruitment of mac-
rophages and neutrophils to injured tissues7. Moreover,
RORγt-expressing (RORγt+) T cells are the main source
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of Th17-producing cells during the early phase of liver
IRI8. We previously demonstrated that RORγt/IL-17A+-
expressing T cells played a crucial role in mediating
hepatic IRI9.
Activating transcription factor 3 (ATF3), a basic
leucine zipper (bZIP) DNA binding protein, is a member
of the ATF/cAMP responsive element binding protein
(CREB) family of transcription factors. Under normal
conditions, ATF3 is expressed at minimal levels. How-
ever, ATF3 can be induced by various stress signals
including ischemia10, ER stress11, endotoxins, and cyto-
kines12. ATF3 is rapidly and preferentially induced
during the early stage of the inflammatory response in
organ IRI, such as in the kidney13,14 and brain15. Over-
expression of ATF3 inhibits oxidative stress-induced
apoptotic cell death in renal cells13, whereas disruption
of ATF3 increases pro-inflammatory cytokine release,
leading to increased susceptibility to endotoxic shock-
induced cell death16.
The mechanistic target of rapamycin (mTOR) forms
two distinct multi-protein complexes, mTOR complex1
(mTORC1) and mTOR complex2 (mTORC2)17. As ana-
typical serine/threonine kinase, mTOR plays important
roles in the regulation of metabolism, cell growth, and
proliferation18. Constitutive mTORC1 activation in mac-
rophages promotes M1 and impairs alternative M2
polarization to enhance the inflammatory response
in vitro and in vivo19,20. Inhibition of mTORC1 reduces
LPS-induced pro-inflammatory cytokine production by
suppressing NF-κB activation in macrophages21. More-
over, increased mTOR activity promotes T helper (Th)
cell responses by reprograming metabolic processes22.
Loss of mTOR results in failure of effector CD4+ T cell
differentiation, whereas it induces forkhead box protein 3
(Foxp3)+ regulatory T cells (Tregs)23. Studies show
that mTOR is a key regulatory factor for Th17
differentiation24.
Hypoxia-inducible factors (HIFs) are transcription
factors that respond to low oxygen concentration or
hypoxia. HIF-1 is a basic helix-loop-helix-PAS hetero-
dimer composed of an alpha and a beta subunit25. HIF-1
alpha subunit (HIF-1α) is regulated by prolyl-
hydroxylase domain (PHD) proteins. Under normoxia,
PHD enzymes catalyze the hydroxylation of two highly
conserved proline residues within the oxygen-
dependent degradation (ODD) domain of HIF-1α by
the E3 ubiquitin ligase von Hippel–Lindau (VHL)-
mediated ubiquitin–proteasome pathway26. However,
reduced PHD activity results in rapid HIF-α accumula-
tion, nuclear translocation, and activation of hypoxia
targeting genes under hypoxic conditions26. HIF-1α has
a pivotal regulatory function in innate and adaptive
immune cells. Disruption of myeloid-specific HIF-1α
inhibits inflammatory responses by impairing
macrophage aggregation and invasion27. HIF-1α dele-
tion in T cells also reduces inflammatory responses by
promoting Foxp3+ Treg and inhibiting TH17 cell dif-
ferentiation28. Moreover, the absence of the mTOR
signaling motif diminishes HIF-1α activity during
hypoxia29, implying a mechanistic link between mTOR
signaling and HIF-1α activity during hypoxia. Despite
the known role of ATF3 in controlling innate inflam-
matory responses and the involvement of HIF-1α in
mTOR signaling, the exact mechanisms by which ATF3
regulates innate immunity and adaptive T cell devel-
opment in IR-triggered liver inflammation remain lar-
gely unknown.
In the present study, we showed that ATF3 deficiency
aggravated IR-induced liver inflammation by activating of
mTOR/p70S6K signaling and increasing TLR4-driven
inflammatory responses. Activation of mTOR upregu-
lated HIF-1α, whereas inhibiting PHD1 activity reduced
Foxp3+ Tregs and promoted Th17 cell differentiation in
IR-induced liver injury. These data indicated that ATF3-
mediated mTOR/p70S6K//HIF-1α signaling is a novel
regulator of innate and adaptive immunity in IR-induced
liver injury.
Results
ATF3 deficiency exacerbates hepatocellular damage in
IR-induced liver injury
To determine the effects of ATF3 in different cells on
liver IRI, the expression of ATF3 was detected in hepa-
tocytes and infiltrating macrophages at various time
points after reperfusion (Fig. 1a and Supplemental Fig-
ure 1). Then, hepatocellular function was assessed in
mouse livers subjected to 90 min of warm ischemia fol-
lowed by 6 h of reperfusion30. The livers of ATF3 KO
mice showed severe edema, sinusoidal congestion, and
necrosis (Fig. 1a, b, score= 2.98 ± 0.35). In contrast,
the livers of WT mice showed mild to moderate edema
and sinusoidal congestion (Fig. 1a, b, score= 1.3 ± 0.34,
p < 0.001). The levels of serum ALT (IU/L) were sig-
nificantly higher in ATF3 KO mice than in the WT
controls (Fig. 1c, 9736 ± 973 vs. 4634 ± 603, p < 0.001).
The results of MPO assay, showed that hepatic neu-
trophil activity (U/g), was 3.2 ± 0.27 in the WT and
6.45 ± 1.32 in the ATF3 KO group (Fig. 1d, p= 0.004).
Consistent with these data, ATF3 KO increased the fre-
quency of TUNEL+ cells in ischemic livers compared
with that in the WT controls (Fig. 1e, f, 80.4 ± 5.68 vs.
39.2 ± 2.28; p < 0.001). Unlike the WT controls, the pro-
tein expression of anti-apoptotic proteins (Bcl-2 and
BCL-xL) was decreased in ATF3 KO livers (Fig. 1g).
This was confirmed by increased caspase-3 activity in
ATF3 KO but not in WT controls (Fig. 1h). These
results indicated that knockdown of ATF3 exacerbated
IR-induced liver damage.
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ATF3 deficiency increases macrophage/neutrophil
trafficking, promotes mTOR and TLR4 activation,
and induces HIF-1α signaling and T cell differentiation
in IR-induced liver injury
To determine whether ATF3 affected inflammatory cell
recruitment in ischemic livers, CD11b+ macrophages and
Ly6G+ neutrophils were detected by immunohistochem-
istry. CD11b+ macrophages and Ly6G+ neutrophils were
increased in ATF3 KO but not in WT mice (Fig. 2a, 41 ±
3.53 vs. 19.4 ± 1.67, p < 0.001; 49.4 ± 4.56 vs. 23.8 ± 3.03,
p < 0.001, respectively). ATF3 KO upregulated TNF-α,
IL-1β, and IL-6 and downregulated TGF-β expression in
ischemic livers compared with the WT controls (Fig. 2b).
The protein expression of phospho-mTOR, phospho-
p70S6K, and TLR4 was upregulated in parallel with PHD1
downregulation and HIF-α upregulation in ATF3 KO
livers compared with WT livers (Fig. 2c). In addition,
ATF3 KO significantly reduced the percentage of splenic
CD4+CD25+Foxp3+ Tregs (Fig. 2d, 8.8 ± 1.18 vs. 13.86 ±
1.42, p < 0.001) and increased CD4+RoRγt+ TH17 cells
(Fig. 2e, 8.75 ± 0.77 vs. 3.59 ± 0.41, p < 0.001), and this was
accompanied by increased serum levels of IL-17A (Fig. 2f,
101.75 ± 16.8 vs. 45 ± 6.05, p= 0.003) compared with the
WT controls. Finally, F4/80 and CD11b double-positive
macrophages were isolated from normal (sham) and IR
livers. Western blot analysis showed that the protein
expression of phospho-mTOR and phospho-p70S6K in
macrophages was higher in ATF3 KO than in WT livers
(Fig. 2g, h). These results suggested that ATF3 played
an important role in the regulation of innate TLR4
Fig. 1 ATF3 deficiency exacerbates hepatocellular damage in IR-induced liver injury. Mice were subjected to 90 min of partial liver warm
ischemia, followed by 6 h of reperfusion. a Western blot analysis of ATF3 protein expression in hepatocytes and macrophages during IR.
Representative histological staining (H&E) of ischemic liver tissue (n= 4–6/group). Original magnification x100. Scale bars= 50 μm. b Liver damage,
evaluated by Suzuki’s score. ***p < 0.001. c Hepatocellular function, as assessed by serum ALT levels (IU/L). Results are expressed as the mean ± SD
(n= 4–6 samples/group), ***p < 0.001. d Liver neutrophil accumulation, as determined by MPO activity (U/g). Mean ± SD (representative of 4–6 mice/
group). **p < 0.01. e, f Liver apoptosis analyzed by TUNEL staining. Results were scored semi-quantitatively by averaging the number of apoptotic
cells (mean ± SD) per field at ×400 magnification. Representative of 4–6 mice/group, ***p < 0.001. g Western blot analysis of BCL-2 and BCL-xL.
β-actin served as an internal control. Data are representative of three experiments. h Caspase-3 activity. Results are expressed as the mean ± SD
(n= 4–6 samples/group), ***p < 0.001
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and adaptive T cell differentiation during liver inflam-
matory injury.
Inhibition of mTOR signaling ameliorates ATF3 deficiency-
mediated liver damage in IR-induced liver injury
To test whether mTOR played a role in ATF3-mediated
immune regulation during liver IRI, mTOR activity in
ischemic livers was inhibitd by rapamycin. Pretreatment
of ATF3 KO mice with rapamycin significantly improved
edema, sinusoidal congestion/cytoplasmic vacuolization,
and necrosis (Fig. 3a, b, 1.1 ± 0.22 vs. 3.2 ± 0.27, p < 0.001),
and decreased the frequency of TUNEL+ cells (Fig. 3a, b,
40 ± 2.54 vs. 82.2 ± 5.8, p < 0.001) in ischemic livers
compared with the DMSO vehicle controls. Consistent
with the histological data, serum ALT levels (IU/L) were
significantly lower in rapamycin-treated ATF3 KO mice
than in the DMSO controls (Fig. 3c, 4852 ± 536 vs. 9786 ±
1092, p < 0.001). Moreover, rapamycin treatment in ATF3
KO mice reduced liver CD11b+ macrophage (Fig. 3d,
21.2 ± 2.16 vs. 40.8 ± 4.32, p < 0.001) and Ly6G+ neu-
trophil recruitment (Fig. 3d, 24.5 ± 0.29 vs. 49.8 ± 4.81,
p < 0.001) compared with the DMSO-treated controls.
The protein expression of phospho-mTOR, phospho-
p70S6K, HMGB1, and TLR4 was decreased, whereas
PHD1 was upregulated and HIF-1α was downregulated
(Fig. 3e), and this was accompanied by the down-
regulation of TNF-α, IL-1β, and IL-6 and the upregulation
of TGF-β expression in rapamycin-treated livers (Fig. 3f)
Fig. 2 ATF3 deficiency increases macrophage/neutrophil trafficking, promotes mTOR and TLR4 activation, induces HIF-1α signaling and
T cell differentiation in IR-induced liver injury. a Liver CD11b+ macrophages and Ly6G+ neutrophils were detected by immunohistochemistry.
Results were scored semi-quantitatively by averaging the number of positively stained cells (mean ± SD)/field at ×400 magnification. Representative
of 4–6 mice/group. ***p < 0.001. b Quantitative RT-PCR-assisted detection of TNF-α, IL-1β, IL-6, and TGF-β expression. Mean ± SD (n= 3-4 samples/
group). *p < 0.05, **p < 0.01. c Western blot analysis of phosphorylated mTOR, phosphorylated p70S6K, PHD1, HIF-1α, and TLR4. β-actin served as an
internal control. Data are representative of three experiments. d, e Foxp3 and RORγt expression in spleen T cells was evaluated by flow cytometry.
Representative of three separate experiments. ***p < 0.001. f ELISA analysis of serum IL-17A levels. Mean ± SD (n= 3–4 samples/group). **p < 0.01.
g Cells were stained with fluorochrome-conjugated anti-F4/80 or -CD11b. F4/80 and CD11b double-positive cells were identified as infiltrating
macrophages. hWestern blot analysis of phosphorylated mTOR and phosphorylated p70S6K in infiltrating macrophages. β-actin served as an internal
control. Data are representative of three experiments
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compared with the DMSO-treated controls. These find-
ings suggested that mTOR was critical for ATF3-
mediated immune regulation during liver IRI.
Blocking ATF3 deficiency-induced mTOR signaling inhibits
TLR4 and HIF-1α signaling, promotes Foxp3+ Tregs, and
inhibits Th17 cell differentiation in vitro
To determine the mechanisms underlying the role of
ATF3 deficiency-induced mTOR signaling in the regula-
tion of innate TLR4, HIF-1α signaling and adaptive T cells
differentiation, mTOR activity was inhibited by rapamycin
in BMMs from ATF3 KO mice. ATF3 KO upregulated
phospho-mTOR and phospho-p70S6K, downregulated
PHD1 and upregulated HIF-1α in LPS-stimulated BMMs
after DMSO treatment. However, inhibition of mTOR by
rapamycin pretreatment downregulated phospho-mTOR,
phospho-p70S6K, and HIF-1α and upregulated PHD1
after LPS stimulation (Fig. 4a). Moreover, rapamycin
treatment downregulated HMGB1 and TLR4 in ATF3-
deficient BMMs compared with the DMSO-treated
controls (Fig. 4b). Decreased TNF-α, IL-1β, and IL-6
levels and increased TGF-β mRNA levels were observed
in rapamycin-treated cells but not in DMSO-treated
controls after LPS stimulation (Fig. 4c). To determine
whether macrophage ATF3 deficiency affected mTOR/
HIF-1α signaling and T cell differentiation, rapamycin-
pretreated ATF3-deficient BMMs were co-cultured with
spleen CD4+ T cells after LPS stimulation. Inhibition of
mTOR in ATF3-deficient BMMs decreased the mRNA
levels of RORγt and IL-17A and increased Foxp3 levels
in spleen CD4+ T cells (Fig. 4d). Consistent with these
data, ELISA-assessed IL-17A levels were significantly
decreased in rapamycin-pretreated groups compared with
those in DMSO-treated controls in co-culture super-
natants (Fig. 4e). To further determine whether PHD1,
HIF-1a, S6K, and mTOR were specifically modulated
by ATF3, we used Ad-ATF3 or Ad-con to overexpress
ATF3 in BMMs from WT mice. ATF3 overexpression
inhibited the expression of phospho-mTOR, phospho-
p70S6K, upregulated PHD1, and downregulated HIF-1α
Fig. 3 Inhibition of mTOR signaling ameliorates ATF3 deficiency-mediated liver damage in IR-induced liver injury. Mice were injected
with the mTOR inhibitor rapamycin (Rap) or DMSO vehicle at 60 min prior to ischemia. a Representative histological staining (H&E, original
magnification ×100) and TUNEL staining of ischemic liver tissue (4–6 mice/group). b Liver damage, as evaluated by Suzuki’s score. ***p < 0.001.
TUNEL staining, results were scored semi-quantitatively by averaging the number of apoptotic cells (mean ± SD) per field at ×400 magnification.
***p < 0.001. c Hepatocellular function, as assessed by serum ALT levels (IU/L). Results are expressed as the mean ± SD (n= 4–6 samples/group).
***p < 0.001. d Liver CD11b+ macrophages and Ly6G+ neutrophils were detected by immunohistochemistry. Results were scored semi-quantitatively
by averaging the number of positively stained cells (mean ± SD)/field at ×400 magnification. Representative of 4–6 mice/group. ***p < 0.001.
e Western blot analysis of phosphorylated mTOR, phosphorylated p70S6K, PHD1, HIF-1α, HMGB1, and TLR4. β-actin served as an internal control.
Data are representative of three experiments. f Quantitative RT-PCR-assisted detection of TNF-α, IL-1β, IL-6, and TGF-β expression. Mean ± SD
(n= 3–4 samples/group). *p < 0.05
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in LPS-stimulated BMMs after Ad-ATF3 or Ad-con
treatment (Fig. 4f). These results suggested that macro-
phage ATF3 regulated innate TLR4 and adaptive T cell
differentiation via the mTOR/HIF-1α-mediated signaling
pathway.
p70S6K mediates mTOR signaling in ATF3-mediated
immune regulation in vitro
As the phosphorylation of S6K acted downstream of
mTOR activation and played an important role in cell
metabolism and transcriptional regulation31, we next
investigated the functional role of macrophage p70S6K
in ATF3-mediated immune regulation in cell cultures.
Unlike the non-specific (NS) siRNA-treated controls,
siRNA-mediated knockdown of p70S6K (si-p70S6K) in
ATF3-deficient BMMs downregulated HMGB1, TLR4,
and NF-κB, upregulated PHD1, and downregulated
HIF-1α after LPS stimulation (Fig. 5a). Treatment of
ATF3-deficient BMMs with si-p70S6K decreased the
mRNA levels of TNF-α, IL-1β, and IL-6 and increased
those of TGF-β in response to LPS stimulation compared
with the NS siRNA-treated controls (Fig. 5b). Using
macrophage (BMM)/spleen CD4+ T cell co-culture
system, p70S6K siRNA treatment in BMMs upregu-
lated Foxp3 and downregulated RORγt and IL-17A
expression in spleen CD4+ T cells (Fig. 5c), and this
Fig. 4 Blocking ATF3 deficiency-induced mTOR signaling inhibits TLR4 and HIF-1α signaling, promotes Foxp3+ Tregs and inhibits Th17 cell
differentiation in vitro. Bone marrow-derived macrophages (BMMs) were isolated from WT and ATF3 KO mice and pretreated with Rap or DMSO
vehicle controls, and then co-cultured with splenic CD4+ T cells after LPS stimulation for 6 h. a, b Western blot analysis of phosphorylated mTOR,
phosphorylated p70S6K, PHD1, HIF-1α, HMGB1, and TLR4 in LPS-stimulated BMMs. β-actin served as an internal control. c Quantitative RT-PCR-
assisted detection of TNF-α, IL-1β, IL-6, and TGF-β in LPS-stimulated BMMs. Mean ± SD (n= 3–4 samples/group). *p < 0.05, **p < 0.01. d Quantitative
RT-PCR-assisted detection of Foxp3, RORγt, and IL-17A in splenic CD4+ T cells after co-culture with Rap or DMSO-pretreated BMMs. Mean ± SD
(n= 3–4 samples/group). *p < 0.05, **p < 0.01. e ELISA analysis of IL-17A levels in co-culture supernatants. Mean ± SD (n= 3–4 samples/group).
**p < 0.01. f Western blot analysis of ATF3, phosphorylated mTOR, phosphorylated p70S6K, PHD1, and HIF-1α in LPS-stimulated BMMs followed
by Ad-ATF3 or Ad-con-pretreatment. β-actin served as an internal control. Data are representative of three experiments
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was accompanied by reduced IL-17A levels after
co-culture (Fig. 5d). These data indicated that mTOR
contributed to ATF3-mediated immune regulation in a
p70S6K-dependent manner.
Disruption of HIF-1α ameliorates ATF3 deficiency-
mediated liver damage and inhibits Th17 cell
differentiation in vivo
Having demonstrated the important role of macrophage
p70S6K/HIF-1α signaling in the modulation of innate and
adaptive immunity in vitro, we next investigated whether
disruption of macrophage HIF-1α in ATF3 KO mice
affected inflammatory responses and T cell differentiation
in mouse liver IRI. An HIF-1α siRNA with an in vivo
mannose-mediated delivery system, which enhances
delivery to cells expressing a mannose-specific membrane
receptor, was used to transfect to macrophages32. First, we
assessed the extent of HIF-1a downregulation after HIF-
1α siRNA or NS siRNA treatment, which showed that
pretreatment with HIF-1α siRNA markedly decreased the
protein levels of HIF-1α (Fig. 6a). The livers of ATF3 KO
mice treated with NS siRNA displayed significant edema,
severe sinusoidal congestion/cytoplasmic vacuolization,
and extensive necrosis (Fig. 6a, b, score= 2.95 ± 0.37).
However, the livers of ATF3 KO mice treated with
mannose-mediated HIF-1α siRNA showed mild to mod-
erate edema without necrosis (Fig. 6a, b, score= 1.25 ±
0.25, p < 0.001), and a lower frequency of TUNEL+ cells
than the NS siRNA-treated controls (Fig. 6a, 83.4 ± 6.54
vs. 44.6 ± 4.2, p < 0.001). These data were consistent with
Fig. 5 p70S6K mediates mTOR signaling in ATF3-mediated immune regulation in vitro. Bone marrow-derived macrophages (BMMs) were
isolated from WT and ATF3 KO mice and transfected with p70S6K siRNA (si-p70S6K), and then co-cultured with splenic CD4+ T cells after LPS
stimulation for 6 h. Non-specific (NS) siRNA served as a control. a Western blot analysis of phosphorylated p70S6K, PHD1, HIF-1α, HMGB1, TLR4, and
NF-κB in LPS-stimulated BMMs. β-actin served as an internal control. b Quantitative RT-PCR detection of TNF-α, IL-1β, IL-6, and TGF-β in LPS-
stimulated BMMs. Mean ± SD (n= 3–4 samples/group). *p < 0.05, **p < 0.01. c Quantitative RT-PCR detection of Foxp3, RORγt, and IL-17A in splenic
CD4+ T cells after co-culture with p70S6K siRNA or NS siRNA-pretreated BMMs. Mean ± SD (n= 3–4 samples/group). *p < 0.05, **p < 0.01. d ELISA
analysis of IL-17A levels in co-culture supernatants. Mean ± SD (n= 3–4 samples/group). **p < 0.01
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the results of hepatocellular function analysis, which
showed that mannose-mediated HIF-1α siRNA treatment
in ATF3 KO mice decreased sALT levels compared with
those in the NS siRNA-treated controls (Fig. 6c, 10,304 ±
1449 vs. 4798 ± 883, p < 0.001). Moreover, HIF-1α siRNA
treatment in ATF3 KO livers increased serum TGF-β
release (Fig. 6d, 281.2 ± 39.55 vs. 602.6 ± 53.04, p < 0.001),
and this was accompanied by a reduction in the percen-
tage of splenic CD4+RoRγt+ TH17 cells (Fig. 6e, 8.74 ±
0.82 vs. 4.01 ± 0.67, p < 0.001) and serum IL-17A levels
(Fig. 6f, 107 ± 25.2 vs. 47 ± 14.9, p= 0.009) compared with
the NS siRNA-treated controls. RORγt and IL-17A
mRNA levels were reduced, whereas Foxp3 levels were
increased in HIF-1α siRNA-treated groups but not the NS
siRNA-treated controls (Fig. 6g). These results suggested
that macrophage HIF-1α signaling was essential for
modulating Th17 cell differentiation and inflammatory
responses in ATF3-mediated immune regulation (Fig. 7).
Discussion
The present study is the first to demonstrate that ATF3-
mediated mTOR/p70S6K/HIF-1α signaling is crucial for
orchestrating inflammatory responses in IR-induced
liver injury. The data can be summarized as follows:
(i) ATF3 deficiency exacerbated IR-induced liver damage,
increased macrophage/neutrophil trafficking, promoted
mTOR and its downstream p70S6K, and activated TLR4/
NF-κB; and (ii) ATF3-mediated mTOR/p70S6K induced
HIF-1α signaling, which was essential for T cell differ-
entiation in liver IRI. These results highlighted the role of
Fig. 6 Disruption of HIF-1α ameliorates ATF3 deficiency-mediated liver damage and inhibits Th17 cell differentiation in vivo. ATF3 KO mice
were injected via the tail vein with a mannose-mediated HIF-1α siRNA or NS siRNA at 4 h prior to ischemia. a Representative histological staining
(H&E, original magnification ×100) and TUNEL staining of ischemic liver tissue (4–6 mice/group). Scale bars= 50 μm. Western blot analysis of HIF-1α
in HIF-1α siRNA or NS siRNA-pretreated livers subjected to IR. β-actin served as an internal control. b Liver damage, as evaluated by Suzuki’s score.
***p < 0.001. TUNEL staining, results were scored semi-quantitatively by averaging the number of apoptotic cells (mean ± SD) per field at ×400
magnification. ***p < 0.001. c Hepatocellular function, as assessed by serum ALT levels (IU/L). Results are expressed as the mean ± SD (n=
4–6 samples/group). ***p < 0.001. d ELISA analysis of serum TGF-β levels. Mean ± SD (n= 3–4 samples/group). ***p < 0.001. e RORγt expression in
spleen T cells was evaluated by flow cytometry. Representative of three separate experiments. ***p < 0.001. f ELISA analysis of serum IL-17A levels.
Mean ± SD (n= 3–4 samples/group). **p < 0.01. g Foxp3, RORγt, and IL-17A in mouse livers. Mean ± SD (n= 3–4 samples/group). *p < 0.05, **p < 0.01
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ATF3-mediated mTOR/p70S6K/HIF-1α signaling in the
regulation of innate and adaptive immunity during liver
inflammatory injury.
ATF3, an oxidative stress-responsive transcription fac-
tor, is associated with a variety of immune and inflam-
matory diseases13,33. Although previous studies showed
that ATF3 modulates inflammatory responses by inhi-
biting TLR4-mediated inflammatory cytokines34,35, little
is known about the exact mechanism by which ATF3
regulates innate TLR4 and adaptive T cell differentiation
in IR-induced liver injury. In addition, ATF3 has multiple
roles in neuroprotection and neuroregeneration36,37. In
the current study, ATF3 deletion increased the inflam-
matory response, as evidenced by the exacerbation of
IR-induced liver damage and increased hepatocellular
apoptosis and intrahepatic macrophage/neutrophil accu-
mulation. Moreover, ATF3 deficiency activated mTOR,
p70S6K, TLR4, and HIF-1α, and downregulated PHD1.
Disruption of ATF3 downregulated Foxp3 and upregu-
lated RORγt-mediated IL-17A expression in IR-induced
liver inflammation. These results underscored the
importance of ATF3 as a negative transcriptional reg-
ulator of innate TLR4 and T cell differentiation during
liver inflammatory injury.
The molecular mechanisms underlying the role of
ATF3 in regulating innate TLR4 and adaptive T cell
differentiation may involve in multiple cellular and
molecular signaling pathways. mTOR, serine/threonine
kinase, function as a core component of two distinct
protein complexes, mTORC1 and mTORC2, which reg-
ulate different cellular functions38, including cell growth,
lipogenesis, protein synthesis, and transcription39,40.
Constitutive mTORC1 activation promotes M1 macro-
phage polarization and increases inflammatory responses
after LPS stimulation19,20. Activation of mTORC1 upre-
gulates TLR4 signaling and pro-inflammatory cytokines
in acute lung injury41. Moreover, mTOR is essential for
T cell proliferation and differentiation42–46. The close
association of ATF3 with mTOR was reported pre-
viously47. Consistent with these results, we found that
ATF3 knockout promoted mTOR activity, whereas inhi-
bition of mTOR ameliorated IR-induced liver injury and
reduced HMGB1 and TLR4 activation, suggesting that
mTOR signaling mediated the role of ATF3 in the reg-
ulation of innate TLR4 during liver IRI.
Further evidence of mTOR signaling-mediated mod-
ulation of innate TLR4 was obtained from our in vitro
study. The results showed that ATF3 deficiency promoted
mTOR and its downstream target gene p70S6K phos-
phorylation in LPS-stimulated BMMs. However, inhibi-
tion of mTOR in ATF3-deficient BMMs reduced p70S6K
activity and downregulated HMGB1 and TLR4, and
this was accompanied by the downregulation of pro-
inflammatory cytokines. Indeed, p70S6K functions as
part of the mTOR signaling pathway. Phosphorylation
of p70S6K is dependent on mTOR, specifically on
mTORC1. The mTORC1-S6K axis controls a variety
of cellular processes and contributes to cell development
and disease31. Disruption of TSC-mediated mTOR/S6K
signaling is associated with several human genetic
disorders48. Consistent with these findings, we found that
disruption of p70S6K in ATF3-deficient BMMs inhibited
Fig. 7 Schematic illustration of the molecular mechanisms underlying the role of mTOR/p70S6K/HIF-1α signaling pathway in the regulation of TLR4
inflammatory signaling and TH17 cells in liver IRI
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TLR4-driven inflammatory responses after LPS stimula-
tion. Notably, ATF3 deletion in LPS-stimulated BMMs
reduced PHD1 activity and increased HIF-1α induction,
whereas p70S6K knockdown upregulated PHD1 and
downregulated HIF-1α, thus decreasing pro-inflammatory
mediators in ATF3-deficient cells. These results suggested
that ATF3-mediated mTOR/p70S6K signaling positively
regulated HIF-1α activity during the inflammatory
response.
One striking finding was that ATF3 deficiency depres-
sed Foxp3+ Tregs, whereas it increased ROR+ Th17 cells
in IR-induced liver inflammation. Although previous
studies showed that mTOR is a major regulator of T cell
differentiation and expansion49, how macrophage ATF3
affects T cell differentiation remains unknown. In the
present macrophage/CD4+ T cell co-culture system,
increased HIF-1α induction in ATF3-deficient BMMs
upregulated RORγt and IL-17A and downregulated Foxp3
expression in splenic CD4+ T cells, and this was accom-
panied by increased IL-17A production. However, inhi-
bition of mTOR by rapamycin in ATF3-deficient BMMs
upregulated PHD1 and downregulated HIF-1α, resulting
in increased Foxp3 and diminished RORγt and IL-17A
levels. Indeed, HIF-1α can regulate innate and adaptive
immune cell functions. Ablation of myeloid-specific
HIF-1α suppresses inflammatory responses by inhibiting
macrophage infiltration and activation27. The contribu-
tion of HIF-1α to the inflammatory response is dependent
on NF-κB activity50. Moreover, HIF-1α promotes Th17
cell development by activating RORγt transcription,
whereas deletion of HIF-1α in T cells promotes Foxp3+
Tregs and decreased RORγt+ Th17 cells28. Consistent
with these results, we found that disruption of HIF-1α in
ATF3 KO mice alleviated IR-induced liver damage and
improved hepatic function, and this occurred in parallel
with reduced RORγt-mediated Th17A levels and
increased Foxp3 expression. Thus, our findings revealed
an essential role for HIF-1α in the control of T cell dif-
ferentiation in ATF3-mediated immune regulation during
liver inflammatory injury.
The effect of macrophage ATF3-mediated mTOR sig-
naling on the ability of HIF-1α to regulate T cell differ-
entiation remains unclear. We showed that ATF3
deficiency increased HIF-1α induction while reducing
PHD1 activity. However, inhibition of mTOR in ATF3
KO mice reduced phosphorylated p70S6K and HIF-1α
and increased PHD1 in ischemic livers. This suggested a
possible mechanistic link between mTOR and HIF-1α in
the regulation of T cell differentiation? Indeed, HIF-1α
stability is primarily modulated by PHD1 in an oxygen-
dependent-manner. PHD1 acts as an oxygen-sensing
enzyme and promotes HIF-1α hydroxylation and protea-
somal degradation in normoxia, whereas inactivated
PHD1 during hypoxia leads to the stabilization of HIF-1α
and its translocation into the nucleus to activate the
transcription of target genes51. Thus, we speculate that
ATF3-mediated mTOR signaling may play an important
role in the regulation of the HIF-1α-PHD1 oxygen-
sensing pathway. As p70S6K activation is modulated by
mTOR, p70S6K may be essential for the regulation of
HIF-1α induction in the mechanism of adaptive T cell
development. This was supported by our further experi-
ments. We used a co-culture system to show that
knockdown of p70S6K in ATF3-deficient BMMs
increased PHD1 and reduced HIF-1α activity, and this
was accompanied by increased Foxp3 and decreased
RORγt-mediated IL-17A levels in splenic CD4+ T cells.
Taken together, these data indicated that ATF3-mediated
mTOR/p70S6K/HIF-1α signaling was crucial for T cell
differentiation in IR-triggered liver inflammation.
In conclusion, we demonstrated that ATF3 deficiency
exacerbated IR-induced liver inflammation by upregulat-
ing mTOR and its downstream target gene p70S6K, which
in turn activated innate TLR4 and increased HIF-1α while
reducing PHD1 activity, leading to depressed Foxp3+
Treg and promoting RORγt+ Th17 cell differentiation.
The present study has increased our knowledge of the
molecular mechanisms underlying the role of ATF3-
mediated mTOR/p70S6K//HIF-1α signaling in the
modulation of innate TLR4 and adaptive T cell differ-
entiation, thus providing potential therapeutic targets in
liver IRI followed by liver transplantation.
Materials and methods
Animals
WT C57BL/6 mice were purchased from the Laboratory
Animal Resources of Nanjing Medical University (NMU).
ATF3 knockout (KO) mice in the C57BL/6 background
were previously described34. Male, 8-week-old WT and
ATF3 KO mice were used in all experiments. This study
was performed in strict accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory
Animals published by the National Institutes of Health.
The animal protocol was approved by the Institutional
Animal Care & Use Committee (IACUC) of Nanjing
Medical University (Protocol Number NMU08-092).
Mouse liver IRI model
A mouse model of warm hepatic ischemia followed by
reperfusion was used, as described30. Mice were injected
with heparin (100 U/kg) and an atraumatic clip was used
to interrupt the arterial/portal venous blood supply to the
cephalad liver lobes. After 90 min the clip was removed,
and mice were killed at 6 h of reperfusion. Mice were
injected with mTOR inhibitor Rapamycin (5 mg/kg, i.p.
Calbiochem, Burlington, MA) or DMSO vehicle at 60 min
prior to ischemia. In some experiments, animals were
injected via tail vein with HIF-1α siRNAs or non-specific
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(control) siRNA, (2 mg/kg) (Santa Cruz Biotechnology,
Shanghai, China) mixed with mannose-conjugated poly-
mers (Polyplus transfection™, Illkirch, France) at a ratio
according to the manufacturer’s instructions 4 h prior
to ischemia as described32.
Hepatocellular function assay
Serum alanine aminotransferase (sALT) levels, an
indicator of hepatocellular injury, were measured by an
automated chemical analyzer (Olympus Automated
Chemistry Analyzer AU5400, Tokyo, Japan).
Histology
Liver sections were stained with hematoxylin and
eosin (H&E). The severity of IRI was graded using Suzuki’s
criteria on a scale from 0 to 452. In this classification, no
necrosis, congestion, or centrilobular ballooning is given a
score of 0, while severe congestion and ballooning degen-
eration and >60% lobular necrosis is given a value of 4.
Immunohistochemistry staining
Liver macrophages and neutrophils were detected using
primary rat anti-mouse CD11b+mAb (Mac-1, M1/70; BD
Biosciences, San Jose, CA) or Ly6G+ mAb (BD Bios-
ciences, San Diego, CA). After incubation with secondary
biotinylated goat anti-rat IgG (Vector, Burlingame, CA),
followed by treatment with immunoperoxidase (ABC Kit,
Vector), positive cells were counted blindly in ten HPF/
section (×400). For immunofluorescence, frozen liver
sections were labeled with primary antibodies ATF3 and
CD11b (Santa Cruz Biotechnology, CA), and then incu-
bated with secondary Cy3-conjugated AffiniPure donkey
anti-goat IgG antibody (Jackson Immunoresearch, PA).
The samples were pre-mounted with VECTASHIELD
medium with DAPI.
Myeloperoxidase activity assay
The presence of myeloperoxidase (MPO) was used as
an index of hepatic neutrophil accumulation2. The change
in absorbance was measured spectrophotometrically at
655 nm. One unit of MPO activity was defined as
the quantity of enzyme degrading 1 μmol peroxide/min
at 25 °C/g of tissue.
TUNEL staining
Liver sections (4 mm) were stained via terminal deox-
ynucleotidyl transferase dUTP nick end labeling (TUNEL)
using the in situ cell death detection kit (Roche-Boeh-
ringer Mannheim, Germany) according to the manu-
facturer’s instructions as previously described2.
Caspase-3 activity assay
Caspase-3 activity was determined by an assay kit
(Calbiochem, La Jolla, CA), as previously described2. Liver
tissues were collected and resuspended in lysis buffer
containing 50mmol/L HEPES, pH 7.4, 0.1% CHAPS, 1
mmol/L DTT, 0.1 mmol/L EDTA, and 0.1% Triton X-100.
Following incubation for 30min on ice, cell lysate was
centrifuged at 16,000 × g for 10 min at 4℃, and the pro-
tein concentration in the supernatants was measured
using the Bradford dye method. The supernatants were
incubated with 200 μM of enzyme-specific colorimetric
caspase-3 substrate at 37 °C for 2 h. Caspase-3 activity was
assessed by measuring the absorbance at a wavelength
of 405 nm with a plate reader. To determine cellular
activity, the inhibitor-treated protein extracts and the
purified caspase-3 (as a standard) were used.
ELISA
IL-17A and TGF-β levels were measured by ELISA
according to the manufacturer’s standard protocols
(eBioscience, San Diego, CA). Absorbance was read on a
Multiscan FC plate reader and analyzed with SkanIt for
Multiscan FC software (Thermo Scientific, Schwerte,
Germany).
Quantitative RT-PCR analysis
Quantitative real-time PCR was performed using the
DNA Engine with Chromo 4 Detector (MJ Research,
Waltham, MA). In a final reaction volume of 25 μl, the
following were added: 1× SuperMix (Platinum SYBR
Green qPCR Kit; Invitrogen, San Diego, CA) cDNA and
10 μM of each primer. Amplification conditions were:
50 °C (2 min), 95 °C (5 min), followed by 40 cycles of 95 °C
(15 s) and 60 °C (30 s). Primer sequences used for the
amplification were shown in Supplementary Table 1.
Western blot analysis
Protein was extracted from liver tissue or cell cultures,
as described53. Monoclonal rabbit anti-mouse ATF3
(Santa Cruz Biotechnology, Shanghai, China), phos-
mTOR, mTOR, phos-p70S6K, p70S6K, HMGB1, TLR4,
NF-κB, HIF-1α, PHD1, Bcl-2, Bcl-xl, and β-actin Abs
(Cell Signaling Technology, San Diego, CA) were used.
The relative quantities of proteins were determined by
densitometer, and expressed in absorbance units (AU).
BMM isolation and in vitro transfection
Murine bone marrow-derived macrophages (BMMs)
were generated as previously described54. In brief, bone
marrow cells were removed from the femurs and tibias of
WT and ATF3 KO mice and cultured in DMEM sup-
plemented with 10% FCS and 20% L929-conditioned
medium. Cells (1 × 106/well) were cultured for 7 days
and then transfected with 100 nM of p70S6K siRNA
(Santa Cruz Biotechnology) using lipofectamine 2000
reagent (Thermo Fish Scientific, Carlsbad, CA). The non-
specific (NS) siRNA as controls. After 24–48 h, cells were
Zhu et al. Cell Death and Disease  (2018) 9:910 Page 11 of 13
Official journal of the Cell Death Differentiation Association
supplemented with 100 ng/ml of LPS for additional 6 h.
In some experiments, BMMs were pretreated with 20 nM
of rapamycin (Calbiochem) or DMSO vehicle at 60 min
prior to LPS stimulation.
Spleen CD4+ T cell isolation
Spleen T cells were purified using the EasySep™
mouse T cell isolation kit (STEMCELL Technologies,
Vancouver, BC, Canada) according to the manu-
facturer’s instructions. T cells were then stimulated
with anti-CD3 (1 µg/ml) and anti-CD28 (2 µg/ml)
(eBioscience). CD4+ T cells were isolated from these
cells using anti-CD4 microbeads (Miltenyi Biotec, Ber-
gisch Gladbach, Germany) according to the manu-
facturer’s instructions.
Macrophage/CD4+ T cell co-culture
Rapamycin or p70S6K siRNA pretreated ATF3 KO
macrophages were counted to 0.5 × 106 cells/ml and cul-
tured on 60mm plates. After the cells stimulated with LPS
(100 ng/ml) for 6 h, spleen CD4+ T cells were then added
into cultures at a macrophage/T cell ratio of 1:5. The co-
cultured cells were incubated for 24 h, and then macro-
phages and spleen CD4+ T cells were harvested for the
real-time PCR and western blot assay.
Flow cytometry analysis
Spleen T cells isolated from WT, ATF3 KO, and HIF-1α
siRNA or NS siRNA-treated ATF3 KO mice were stained
with anti-mouse CD4-PE-Cyanine5, CD25-PE, RoRγt-PE,
and Foxp3-FITC mAbs (eBioscience) according to the
manufacturer’s instructions. PE-labeled rat anti-mouse
IgG2a isotypes were used as negative controls. Measure-
ments were performed using a FACS Calibur flow cyt-
ometer (BD Biosciences). Data analysis was performed
using Cell Quest software. Liver NPCs were isolated from
sham or IR livers, as described above55. A total of 1 × 106
cells were incubated with purified rat anti-mouse CD16/
32 for 10min and stained with rat anti-mouse F4/80-
PeCy5/PE, CD11b-FITC, and isotype-matched negative
control Abs (eBioscience, San Diego, CA) were added to
the cell suspension. After 20 min of incubation in the
dark, the cells were washed with PBS and subjected to
flow cytometric analysis with FACS Calibur (BD Bios-
ciences). For intracellular staining of CD206 and inducible
NO synthase, cells were fixed in 4% formaldehyde for
20min after the staining of F4/80 and CD11b, and washed
twice with 1× permeabilization buffer (eBioscience). After
incubation with CD206-APC (BioLegend, San Diego,
CA) and inducible NO synthase-PE (eBioscience) in
1× permeabilization buffer for 20min in the dark, the
cells were washed with PBS and subjected to flow cyto-
metric analysis.
Adenovirus gene transfer
Adenoviral vector encoding the mouse ATF3 gene
(Ad-ATF3) and negative control (Ad-con) was con-
structed, packaged, purified, and titrated at Genechem
Co. Ltd. For adenovirus-mediated gene transfer, Ad-ATF3
or Ad-con was transfected into macrophages from WT
mice at a final concentration of 0.5 × 106 cells/ml for 48 h.
After 48 h, the overexpression efficiency of Ad-ATF3 was
evaluated by western blot.
Statistical analysis
Data are expressed as mean ± SD and analyzed by
Student’s t tests. Per comparison, two-sided p values less
than 0.05 were considered statistically significant. Multi-
ple group comparisons were performed using one-way
ANOVA with a post hoc test. All statistical analysis was
performed using SPSS-3 software.
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